This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: FB HPQ MAR GPS ZNGA

Rockwood (ROC) rated new Buy at BofA/Merrill. $58 price target. Company can see earnings growth accelerate in 2014.

Skyworks (SWKS) rated new Buy at Lazard. $30 price target. Stock can recover and the company emerges as the clear winner from the iPhone 5.

Thermo Fisher (TMO) upgraded at Wells to Outperform from Market Perform, Wells Fargo said. Company is leveraged to a strong mass spectrometer market.

Vanguard Natural (VNR) rated new Buy at UBS. $33 price target. Growing steadily and paying monthly.

Zynga (ZNGA - Get Report) downgraded at Baird to Neutral, Robert Baird said. $3 price target. Company cut its guidance again. Zynga downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. $2.70 price target. Estimates also cut, given the company's new guidance.


Alexion Pharmaceuticals (ALXN) numbers raised at Oppenheimer. Shares of ALXN now seen reaching $134, Oppenheimer said. Estimates also raised on headroom in the orphan disease franchise. Outperform rating.

Endo (ENDP) numbers cut at UBS. Shares of ENDP now seen reaching $45, UBS said. Estimates also lowered following investor day. Buy rating.

Facebook (FB - Get Report) estimates, target reduced at JP Morgan. Shares of FB now seen reaching $28, according to JP Morgan. Estimates also cut, given the company's exposure to ZNGA. Overweight rating.

Gap (GPS) estimates, target increased at Piper. GPS estimates were raised through 2014, Piper Jaffray said. Company is carrying sales momentum into the Fall season. Overweight rating and new $42 price target.

Informatica (INFA) numbers cut at JMP. INFA estimates were reduced through 2013, JMP Securities said. Company cut guidance for a second straight quarter. Outperform rating and new $38 price target.

Impax Labs (IPXL) numbers boosted at BofA/Merrill. Shares of IPXL now seen reaching $25, according to Bank of America/Merrill Lynch said. Estimates also upped, as the company is seeing higher generic sales. Underperform rating.

Marriott (MAR - Get Report) estimates, target raised at Nomura. Shares of MAR now seen reaching $48, according to Nomura. Estimates also increased, given higher expected RevPAR growth. Buy rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ZNGA $2.84 2.20%
BRCD $11.88 0.72%
FB $82.75 -0.53%
HPQ $31.30 -0.87%
MAR $81.15 -0.43%


DOW 17,875.52 -100.79 -0.56%
S&P 500 2,079.06 -7.18 -0.34%
NASDAQ 4,926.8140 -20.6270 -0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs